You have 9 free searches left this month | for more free features.

coronary microvascular dysfunction

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mental Stress Reactivity in Women With CMD

Recruiting
  • Post-menopause
  • Study Procedures
  • Atlanta, Georgia
  • +3 more
Dec 7, 2022

Microvascular Coronary Resistance and Absolute Coronary FLOW in

Active, not recruiting
  • Chronic Total Occlusion of Coronary Artery
  • +3 more
  • Invasive coronary physiology
  • Barcelona, Spain
  • +3 more
Mar 2, 2022

Coronary Vasospasm, Coronary Microvascular Dysfunction, Non-Obstructive Coronary Atherosclerosis Trial in Netherlands (Coronary

Enrolling by invitation
  • Coronary Vasospasm
  • +2 more
  • Coronary Function Test
  • Patient questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +8 more
Oct 12, 2023

Cardiac Diastolic Function and Coronary Microvascular Function

Active, not recruiting
  • Ischemic Heart Disease
  • +3 more
  • Echocardiography
  • Coronary flow reserve and index of microcirculatory dysfunction
  • Iowa City, Iowa
  • +3 more
Sep 6, 2022

CMR in T2DM: The NSR Cohort

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • +4 more
  • All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion
  • Slagelse, Denmark
    Slagelse Hospital, department of cardiology and endocrinology, m
Jun 13, 2023

Angina CCS Classe II-IV - IMR, RFR, FFR,CFR Trial in Naples

Active, not recruiting
  • Angina CCS Classe II-IV - IMR, RFR, FFR,CFR
    • Naples, Italy
      Federico II University of Naples
    Jan 9, 2023

    Microvascular Coronary Dysfunction Trial in Los Angeles (Handgrip, Altitude simulation, Leg exercise)

    Recruiting
    • Microvascular Coronary Dysfunction
    • Handgrip
    • +2 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Aug 17, 2021

    Angina Pectoris, Coronary Heart Disease, X Syndrome, Angina Trial in ShangHai (MUSK pill)

    Recruiting
    • Angina Pectoris
    • +3 more
    • MUSK pill
    • ShangHai, Shanghai, China
      Huashan Hospital Fudan University
    Jul 20, 2021

    Heart Failure With Preserved Ejection Fraction Trial in Seoul (Adenosine stress echocardiography with the evaluation of coronary

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Adenosine stress echocardiography with the evaluation of coronary artery blood flow
    • Seoul, Korea, Republic of
      Korea University Anam Hospital
    Aug 30, 2021

    Clinical Implication of CMD in HFpEF Without Significant CAD

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Coronary Microvascular Dysfunction
    • Invasive physiologic evaluation (fractional flow reserve, coronary flow reserve, index of microcirculatory resistance)
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jan 9, 2022

    A Prospective, Multi-center Clinical Trial for Evaluating

    Completed
    • Coronary Microvascular Dysfunction
    • Angiography-derived Index of Microcirculatory Resistance
    • Pressure wire-based Index of Microcirculatory Resistance
    • Beijing, Beijing, China
    • +2 more
    Mar 28, 2022

    Obstructive Hypertrophic Cardiomyopathy

    Completed
    • Microvascular Dysfunction
    • +2 more
      • Beijing, Beijing, China
        Fuwai Hospital, China National Center for Cardiovascular Disease
      Jan 11, 2023

      Microvascular Disease as Assessed by PET and Graft Injury by

      Not yet recruiting
      • Cardiac Allograft Vasculopathy
      • +2 more
      • Blood draw to measure the levels of dd-cf DNA
      • New Haven, Connecticut
        Yale New Haven Health
      Mar 6, 2023

      WISE CVD - Continuation (WISE HFpEF)

      Recruiting
      • Microvascular Coronary Dysfunction
      • Cardiovascular Disease
      • Coronary Angiography
      • +6 more
      • Los Angeles, California
        Cedars-Sinai Women's Heart Center
      Aug 17, 2021

      Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF

      Recruiting
      • Coronary Microvascular Dysfunction
      • Heart Failure With Preserved Ejection Fraction (HFpEF)
        • Los Angeles, California
        • +1 more
        Aug 17, 2021

        Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary Trial in Germany, Switzerland (Bisoprolol,

        Recruiting
        • Coronary Microvascular Dysfunction
        • +5 more
        • Bad Nauheim, Germany
        • +14 more
        Mar 15, 2022

        Coronary Artery Disease, Microvascular Dysfunction Trial in Mainz (observational only- no intervention)

        Recruiting
        • Coronary Artery Disease
        • Microvascular Dysfunction
        • observational only- no intervention
        • Mainz, Germany
          University Medical Center Mainz - 2 Medizinische Klinik
        Mar 29, 2022

        Left Ventricular Systolic Function in Different Types of

        Completed
        • Coronary Microvascular Dysfunction
        • Obstructive Coronary Heart Disease
        • Two dimensional speckle tracking imaging
        • Beijing, Beijing, China
          Department of Cardiology, Peking University Third Hospital, NHC
        Jul 12, 2021

        Microvascular Angina, Coronary Vasospasm, Microvascular Ischemia of Myocardium Trial in Nijmegen, Eindhoven, Rotterdam

        Recruiting
        • Microvascular Angina
        • +2 more
        • Diltiazem Hydrochloride
        • Placebo
        • Nijmegen, Gelderland, Netherlands
        • +2 more
        Feb 25, 2021

        Coronary Microvascular Dysfunction Trial in Los Angeles, Rochester (CLBS16)

        Completed
        • Coronary Microvascular Dysfunction
        • CLBS16
        • Los Angeles, California
        • +1 more
        Dec 11, 2020

        Diagnostic and Prognostic Value of Angiography-derived IMR

        Not yet recruiting
        • Coronary Microvascular Dysfunction
        • Myocardial Ischemia
        • Angiography-drived Index of Microcirculatory Resistance
        • Shanghai, China
          Shanghai Tenth People's Hospital
        Mar 28, 2021

        HCM - Hypertrophic Non-Obstructive Cardiomyopathy Trial in Milan (Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die

        Completed
        • HCM - Hypertrophic Non-Obstructive Cardiomyopathy
        • Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
        • Milan, Italy
          IRCCS Ospedale San Raffaele
        Dec 9, 2020

        Acute Coronary Syndrome Trial in Madrid (Microbiota analysis, Immunological analysis, Proteome analysis)

        Completed
        • Acute Coronary Syndrome
        • Microbiota analysis
        • +6 more
        • Madrid, Spain
          Hospital General Universitario Gregorio Marañón
        Sep 30, 2022

        A Clinical Study of Fundus OCTA for the Identification of CMD

        Not yet recruiting
        • Coronary Microvascular Disease
        • CaIMR
        • (no location specified)
        Feb 14, 2023

        The MASTER-PACT Study

        Not yet recruiting
        • Microvascular Coronary Artery Disease
        • Coronary Artery Disease
          • (no location specified)
          Oct 4, 2023